| Business Type | Exporter, Supplier, Retailer |
| Size | 2 mg tablets,2 mg |
| Type | Targeted therapy / MEK inhibitor,Prescription anticancer drug |
| Material | Trametinib |
| Click to view more | |
Product Details
Bottle contains 30 tablets
Includes desiccant to protect from moisture
Outer carton labeled with batch/lot number and expiration date
Storage: Refrigerate at 2–8 °C (36–46 °F); keep bottle tightly closed
Mekinist (generic name: trametinib) is a targeted anticancer medication used to treat certain types of cancer by blocking key proteins that help cancer cells grow and multiply. It is specifically a MEK inhibitor, targeting enzymes (MEK1 and MEK2) in the MAPK signaling pathway that are often overactive in cancers with specific genetic mutations.
-
Active ingredient: Trametinib
-
Class: MEK inhibitor (mitogen-activated protein kinase kinase inhibitor)
-
It slows or stops cancer cell growth by blocking MEK1/MEK2 activity, which are proteins downstream of the BRAF gene in the signaling pathway that promotes tumor cell division.
Trametinib blocks the MEK enzymes, which are part of a signaling pathway that cancer cells with BRAF V600 mutations use to grow uncontrollably. By inhibiting this pathway, Mekinist helps slow down or halt tumor progression.
Email: peptidevera@
